Use of a vascular reconstruction device to salvage acute ischemic occlusions refractory to traditional endovascular recanalization methods
- 1 March 2010
- journal article
- research article
- Published by Journal of Neurosurgery Publishing Group (JNSPG) in Journal of Neurosurgery
- Vol. 112 (3), 557-562
- https://doi.org/10.3171/2009.8.jns09231
Abstract
Object Acute revascularization has been associated with improved stroke outcomes. The Prolyse in Acute Cerebral Thromboembolism (PROACT II) trial achieved recanalization rates of 66%. The Multi Mechanical Embolus Removal in Cerebral Ischemia (Multi MERCI) trial achieved recanalization in 70% of patients. However, these interventional tools are not always successful. The Enterprise vascular reconstruction device was recently introduced for treatment of cerebral aneurysms previously untreatable with endovascular techniques. The authors evaluated a multicenter experience using this stent as a salvage revascularization tool for acute stroke treatment. Methods Four medical centers participated in a retrospective review of endovascularly treated patients with acute stroke for cases treated with the Enterprise stent after routine interventions had been unsuccessful. Data collected included preprocedure information, intraprocedure findings, and outcomes. Results Twenty patients with acute stroke (mean age 61.6 ± ...Keywords
This publication has 26 references indexed in Scilit:
- Navigability Trumps All: Stenting of Acute Middle Cerebral Artery Occlusions with a New Self-Expandable StentAmerican Journal Of Neuroradiology, 2008
- The Penumbra System: A Mechanical Device for the Treatment of Acute Stroke due to ThromboembolismAmerican Journal Of Neuroradiology, 2008
- Multimodal Reperfusion Therapy for Acute Ischemic StrokeStroke, 2006
- Aggressive Therapy With Intravenous Abciximab and Intra-Arterial rtPA and Additional PTA/Stenting Improves Clinical Outcome in Acute Vertebrobasilar OcclusionStroke, 2005
- MERCI 1Stroke, 2004
- Coronary Angioplasty with or without Stent Implantation for Acute Myocardial InfarctionNew England Journal of Medicine, 1999
- Intra-arterial Prourokinase for Acute Ischemic StrokeJAMA, 1999
- CACNA1A mutationsNeurology, 1999
- PROACT: A Phase II Randomized Trial of Recombinant Pro-Urokinase by Direct Arterial Delivery in Acute Middle Cerebral Artery StrokeStroke, 1998
- Intravenous thrombolysis with recombinant tissue plasminogen activator for acute hemispheric stroke. The European Cooperative Acute Stroke Study (ECASS)JAMA, 1995